Litigation Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)
✉ Email this page to a colleague
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)
| Docket | ⤷ Subscribe | Date Filed | 2015-08-24 |
| Court | District Court, E.D. Texas | Date Terminated | 2017-10-16 |
| Cause | 35:271 Patent Infringement | Assigned To | William C. Bryson |
| Jury Demand | Both | Referred To | |
| Parties | APOTEX CORP. | ||
| Patents | 8,501,174; 8,629,111; 8,633,162; 8,642,556; 8,648,048; 8,685,930; 9,248,191 | ||
| Attorneys | Shashank Upadhye | ||
| Firms | Naman Howell Smith & Lee PLLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Biologic Drugs cited in Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Subscribe and ⤷ Subscribe .
Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-08-24 | 1 | Complaint | U.S. Patent No. 8,629,111, # 3 Exhibit 2 - U.S. Patent No. 8,633,162, # 4 Exhibit 3 - U.S. Patent No. … United States Patent Nos. 8,629,111 (“the ‘111 Patent”), 8,633,162 (“the ‘162 Patent”), 8,642,556 (“…Background A. Patents-In-Suit 1. U.S. Patent No. 8,629,111 73. On…‘556 Patent”), 8,648,048 (“the ‘048 Patent”), and 8,685,930 (“the ‘930 Patent”) under the Patent Laws…8,642,556, # 5 Exhibit 4 - U.S. Patent No. 8,648,048, # 6 Exhibit 5 - U.S. Patent No. 8,685,930)(Hill, Jack) | External link to document |
| 2016-04-19 | 130 | Memorandum & Opinion | several patents relating to RESTASIS— United States Patent Numbers 8,629,111 (“the ’111 patent”), 8,633,162…,162 (“the ’162 patent”), 8,642,556 (“the ’556 patent”), 8,648,048 (“the ’048 patent”), 8,685,930 (“the…“the ’930 patent”), and 9,248,191 (“the ’191 patent”). Those patents are listed in the “Orange Book,” …’930 patents. Allergan later amended its complaint to include the ’191 patent after that patent issued… I. BACKGROUND This patent infringement action arises from Abbreviated New | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
